Could NAPQI Contribute to Paracetamol Analgesia? Redox Modulation of Kv7 Ion Channels

Paracetamol (acetaminophen, APAP) is one of the most widely used analgesic and antipyretic drugs worldwide, yet its mechanism of action remains incompletely understood. While several pathways have been proposed, including cyclooxygenase inhibition and endocannabinoid modulation via AM404, none fully account for its pharmacological profile. The reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI) is classically associated with hepatotoxicity, but electrophilic species can also modulate protein function through covalent modification of redox-sensitive residues. Recent evidence indicates that NAPQI can enhance neuronal Kv7 (KCNQ) channel activity, reducing neuronal excitability. Here, we examine the hypothesis that NAPQI formation during therapeutic APAP metabolism may contribute to analgesia via redox-dependent modulation of nociceptive ion channels. We integrate current knowledge on APAP metabolism, ion channel redox regulation, and neuronal excitability, and complement this with order-of-magnitude quantitative estimates and sensitivity analyzes. These analyzes indicate that the expected magnitude of NAPQI formation in neural tissue is likely to remain below current analytical detection limits while still being compatible with transient, spatially restricted concentrations in cellular microdomains that could modulate nearby targets. Although direct in vivo evidence remains lacking, this framework raises the possibility that localized and transient NAPQI signaling may contribute to APAP-induced modulation of neuronal excitability while remaining difficult to detect using conventional bulk analytical approaches. We outline key experimental strategies required to test this hypothesis and discuss its implications for understanding APAP pharmacology and the broader role of electrophilic metabolites in physiological signaling.